Got a patent, now where to validate?
For smaller companies and universities, deciding where to validate a pharma patent can be difficult. Sarah Kostiuk-Smith of Mewburn Ellis looks at the options within the European Patent Convention countries.
- Patent filing strategies for pharma startups 16-03-2021
- The importance of Minerva Surgical v Hologic 02-02-2021
- What 2020 means for the life sciences 15-12-2020
- Pricing, patents and the PMPRB in Canada 14-12-2020
- The doctrine of equivalents in the medtech arena 18-11-2020
Latest big pharma news
Allergan’s Forest to face jury in antitrust suit over Alzheimer drug
15-06-2021
Allergan subsidiary Forest Laboratories will have to argue its case before a jury over claims that it used pay-for-delay deals to keep generic copies of blockbuster Alzheimer drug, Namenda, from the marketplace.
France backs COVID-19 vaccine IP waiver
14-06-2021
